Four-Factor Exogenous Ketone Screen
Screen ketone supplements for usability, kinetics, and safety
- Difficulty
- Easy
- Time to result
- ~days to results
- Steps
- 5
- Confidence
- 98%
D'Agostino evaluates exogenous ketones through four factors: palatability, tolerability, pharmacokinetics, and toxicity. Palatability determines whether someone will take a product; tolerability captures nausea and gastrointestinal effects; pharmacokinetics describes the rise, peak, and clearance of ketones; and toxicity asks what repeated metabolism of the ingredients may do. He is particularly cautious about chronic use of 1,3-butanediol and 1,3-butanediol-based esters. A rapid ketone spike can provoke insulin, suppress endogenous ketone production, and be followed by low glucose and low ketones. He says formulation, taking a product with food, or combining it with tolerated MCT oil may alter the response, but does not erase the need to evaluate chronic safety, especially in older adults or people with compromised liver function.
Origin
Extracted from The Tim Ferriss Show as Dominic D'Agostino's explicit four-part screen for exogenous ketone products.
Core principles
- 01A supplement must be usable before its theoretical benefits matter
- 02The rate of ketone rise and fall matters alongside the peak
- 03Acute tolerability does not establish chronic safety
- 04Formulations can behave differently from isolated molecules
How to run it
- 1
Test palatability
Determine whether the taste and mouthfeel are acceptable enough for the intended frequency of use. A product that cannot be consumed consistently fails before its metabolic effects matter.
Watch out Do not mask an ingredient so thoroughly that you accidentally take a larger dose than intended.
- 2
Test tolerability
Begin conservatively and observe nausea, dizziness, sedation, and gastrointestinal effects. Separate immediate tolerability from assumptions about long-term safety.
Pro tip D'Agostino says MCT oil is generally more tolerable with a meal than on an empty stomach.
Watch out D'Agostino describes 1,3-butanediol as capable of narcotic-like effects, dependency, and withdrawal.
- 3
Map pharmacokinetics
Measure how quickly ketones rise, how high they peak, and how long they remain elevated. Watch for a sharp rise followed by an energy crash rather than rewarding the peak alone.
Pro tip Taking a ketone ester with food or tolerated MCT oil may slow absorption and buffer the response.
Watch out A potent rapid rise may increase insulin and temporarily suppress the body's own ketone production.
- 4
Investigate toxicity
Identify the active molecule and review chronic exposure evidence, not merely short acute studies. Consider liver function, age, alcohol use, medications, and intended duration.
Pro tip Track longitudinal clinical data with a qualified clinician if repeated use is being considered.
Watch out Normal liver transaminases do not necessarily exclude liver pathology, according to D'Agostino's discussion.
- 5
Match use to context
Decide whether the product is for an acute medical context, occasional performance use, or daily lifestyle use. Apply a higher evidence and safety bar as frequency and duration increase.
Watch out Do not generalize an acute experimental benefit into a claim of safe chronic use.
In the wild
D'Agostino reports that a large dose of a ketone monoester can raise his ketones rapidly and clear within about two hours. He says the response also releases insulin, suppresses his own ketone production, and can leave him both hypoketotic and hypoglycemic, creating an energy deficit in the brain.
→ The product scores poorly on pharmacokinetics despite producing a high ketone peak.
D'Agostino describes animal work in which chronic exposure produced concerning liver findings, and a two-week self-experiment at doses that maintained roughly two millimolar ketones in which his liver enzymes rose. He emphasizes that long-term human data are sparse.
→ The chronic-use question remains a safety concern even when the compound can elevate ketones effectively.
Common mistakes
Optimizing only for the peak
A high peak can conceal rapid clearance, insulin release, suppressed endogenous ketogenesis, and a subsequent crash.
Equating short studies with chronic safety
D'Agostino says long-term human evidence for 1,3-butanediol agents is sparse and raises concerns from animal work and self-testing.
Ignoring age and liver capacity
He argues that older adults may detoxify these compounds less effectively and face added dizziness and fall risk.
Is it for you?
Best for
It is best for evaluating whether a ketone supplement is practical and plausibly appropriate before repeated use.
Not ideal for
It is not a substitute for clinical assessment, toxicology data, or medical supervision in disease treatment.
From the transcript
“if you have a very rapid rate of rise of ketones, that can trigger an insulin response.”
“when consumed chronically when we go beyond our experimental window and give these things chronically as like a lifestyle exogenous ketone and then we sacrifice…”
From the episode
#845: How to Use Ketosis for Enhanced Mood, Cognition, and Long-Term Brain Protection — A Practical and Tactical Guide with Dr. Dominic D'Agostino (Plus: Deconstructing Tim’s Latest Keto Experiment)